Clark Wesley bought IBRX
June 9, 2026 · Form 4 insider transaction
Clark Wesley bought 65,600 shares of ImmunityBio, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
65,600
Price
$0.00
Total value
N/A
InsiderClark Wesley
Role—
CompanyImmunityBio, Inc. (IBRX)
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJune 9, 2026
Filing dateJune 10, 2026
Shares owned after65,600
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's 2025 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 9, 2027 or the date immediately preceding the next annual meeting of stockholders.